Back
Climb Bio, Inc. Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
56
CLYM
Climb Bio, Inc.
Last Price:
$6.56
Seasonality Move:
23.04%
7 Day Trial
ALL ACCESS PASS
$
7
Climb Bio, Inc. Stock Forecast
-
Over the next 52 weeks, Climb Bio, Inc. has on average historically risen by 71% based on the past 4 years of stock performance.
-
Climb Bio, Inc. has risen higher in 1 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 25%
-
Is Climb Bio, Inc. Stock Undervalued?The current Climb Bio, Inc. [CLYM] share price is $6.56. The Score for CLYM is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
-
CLYM is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
Will Climb Bio, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Climb Bio, Inc. has on average historically risen by 71% based on the past 4 years of stock performance.
Climb Bio, Inc. Stock Rating
Buy
56
Climb Bio, Inc. (CLYM)
is a Buy
Is Climb Bio, Inc. overpriced?
-
Climb Bio, Inc. has risen higher in 1 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 25%
Climb Bio, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
climbbio.com
52-Week Data
52-Week High:
8.04
52-Week Low:
1.05
Prediction Charts
Market Cap:
295.8M
Price in USD:
6.56
Volume:
440.8K
Beta:
-0.21
Technical Analysis
SMA50:
6.22
SMA100:
4.66
SMA200:
3.25
52-Wk Change:
442.15%
Stock Predictions
-
Is Climb Bio, Inc. stock public?Yes, Climb Bio, Inc. is a publicly traded company.
-
What is the Climb Bio, Inc. stock quote today?The Climb Bio, Inc. stock price is 6.56 USD today.
-
How to buy Climb Bio, Inc. stock online?You can buy Climb Bio, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Mar-16 | 7.07 | 7.13 | 7.38 | 6.95 |
| Mar-17 | 7.13 | 7.12 | 7.18 | 6.86 |
| Mar-18 | 7.18 | 7.12 | 7.36 | 6.95 |
| Mar-19 | 6.96 | 6.98 | 7.22 | 6.68 |
| Mar-20 | 6.92 | 6.11 | 7.11 | 6.00 |
| Mar-23 | 6.12 | 6.54 | 6.67 | 5.87 |
| Mar-24 | 6.77 | 6.68 | 7.10 | 6.37 |
| Mar-25 | 6.79 | 6.98 | 7.00 | 6.61 |
| Mar-26 | 6.96 | 7.11 | 7.20 | 6.86 |
| Mar-27 | 6.99 | 7.02 | 7.46 | 6.94 |
| Mar-30 | 6.93 | 6.54 | 7.08 | 6.48 |
| Mar-31 | 6.60 | 6.85 | 7.15 | 6.57 |
| Apr-1 | 6.83 | 6.95 | 7.29 | 6.79 |
| Apr-2 | 6.82 | 6.56 | 7.22 | 6.42 |
Climb Bio, Inc. Earnings
Climb Bio, Inc. Earnings Report: Per Share Climb Bio, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Climb Bio, Inc. Forecast Revenue Growth
Climb Bio, Inc. Stock Analysis: Historical quarterly revenues per share for Climb Bio, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.14 per share, a decrease next quarter of $0.15 per share, a decrease this year of $0.33 per share, and a decrease next year of $0.30 per share.
* Climb Bio, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.